Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pimicotinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abbisko Presents Phase 2 Pimicotinib Data in Chronic GVHD at ASH
    Abbisko Presents Phase 2 Pimicotinib Data in Chronic GVHD at ASH

    08 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/2024-ash-oral-presentationabbisko-presents-promising-preliminary-phase-2-study-results-of-pimicotinib-in-the-treatment-of-chronic-graft-versus-host-disease-cgvhd-at-the-66th-ash-annual-meeting-302325684.html

    PR NEWSWIRE
    08 Dec 2024
    Share Share
    Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
    Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug

    12 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/merck-kgaas-phase-3-rare-tumor-trial-hits-goal-teeing-rivalry-daiichi-and-ono?itm_source=parsely-api

    FIERCE BIOTECH
    12 Nov 2024
    Share Share
    Merck KGaA plans China submission after win for tumor drug
    Merck KGaA plans China submission after win for tumor drug

    12 Nov 2024

    // ENDPTS

    https://endpts.com/merck-kgaa-plans-china-submission-after-late-stage-win-for-tumor-drug/

    ENDPTS
    12 Nov 2024
    Share Share
    Pimicotinib Shows Improved Outcomes in Ph 3 Trial for Tenosynovial Tumor
    Pimicotinib Shows Improved Outcomes in Ph 3 Trial for Tenosynovial Tumor

    11 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pimicotinib-significantly-improved-outcomes-for-patients-with-tenosynovial-giant-cell-tumor-in-a-global-phase-iii-trial-302301539.html

    PR NEWSWIRE
    11 Nov 2024
    Share Share
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib
    Abbisko announces that EMA has granted orphan drug designation forPimicotinib

    08 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutic-announces-that-ema-has-granted-orphan-drug-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302028394.html

    PR NEWSWIRE
    08 Jan 2024
    Share Share
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib
    Abbisko Announces that FDA Has Granted Fast Track Designation for Pimicotinib

    13 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbisko-therapeutics-announces-that-us-fda-has-granted-fast-track-designation-for-its-csf-1r-inhibitor-pimicotinib-absk021-302014220.html

    PR NEWSWIRE
    13 Dec 2023
    Share Share